ZTS logo

ZTS Zoetis Inc.

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$79.11
-1.68 (-2.08%)

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses.…

Market Cap: $32.14Bwww.zoetis.com

Price

$72.97-53.12%
$71.86$100.16$128.46$156.76
Jul 2025Aug 2026

Social Signal Score

54
5d
—
30d
55
15 mentions
+0.0%
60d
53
30 mentions
+0.0%
90d
54
45 mentions
+0.0%
marketaux: 4 · rss: 13 · news: 28

Analyst Ratings

32 analysts
Holdconsensus
Strong Buy 1Buy 13Hold 18Sell 0Strong Sell 0
Avg price target$84.75+7.1%
Low $74Median $84High $95
Current Consensus

52-week range

$71.86$156.76
Last close
$72.97
Off 52w high
-53.5%
200-day average
$106.60
vs 200-day
-31.5%

Compare with other stocks off their highs

Revenue

$2.39B+87.24%
$1.23B$1.64B$2.06B$2.47B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$6.34
$6.32–$6.35
15 analysts
FY2026
$6.32-0% YoY
$6.24–$6.41
9 analysts
FY2027
$6.30-0% YoY
$5.92–$6.59
10 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Kristin C. Peck
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
14,500
Beta
0.68
Country
US
Piotroski score
6 / 9 (Middling)
Altman Z-score
4.70
www.zoetis.com